Target intelligence / Profile preview

RPS5 pseudogene 2 (RPS5P2)

Target
RPS5P2
Molecular classification
Other, Pseudogene, Processed pseudogene (non-coding)
01

Overview

RPS5 pseudogene 2 is a processed, non-coding pseudogene derived from the ribosomal protein S5 gene. Pseudogenes are mutated DNA sequences that closely resemble functional protein-coding genes but typically do not encode active proteins. While RPS5P2 does not code for a protein product nor serve as a typical drug target, research suggests some ribosomal protein pseudogenes can regulate their parent genes through RNA-based mechanisms, such as RNA interference or miRNA sponging. Such modulation may have functional consequences in processes like synaptic scaling and stress responses, but direct evidence for RPS5P2-specific function is lacking. RPS5P2 is not considered a therapeutic target[2][7][6][8]. Key points: - RPS5P2 is not a receptor, enzyme, transporter, or therapeutic target, but rather a processed pseudogene. - It may participate in genomic regulation of its parent ribosomal protein gene at the RNA level, but has no direct protein function. - There are no known drugs, biomarkers, or clinical safety considerations associated with this locus. - The nomenclature and abbreviations provided are correct; the entry itself is valid but should not be considered a canonical pharmacological target[7][2].

Other names
RPS5P2RPS5_4_1727ribosomal protein S5 pseudogene 2
02

Biological functions

May have roles in regulation of parent gene expression via RNA interference or competing endogenous RNA effectsNo direct protein-coding or structural role; indirect regulatory functions only
03

Disease associations

OtherPossible regulatory involvement in diseases related to dysfunction of ribosomal proteins, for example, modulating synaptic protein synthesis during major depressive disorder, though evidence is indirect and general to RP pseudogenes as a class

Beyond the preview

Go deeper on RPS5 pseudogene 2 (RPS5P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RPS5 pseudogene 2 (RPS5P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call